Intraday -05-04-07.
Download today's file by :Clicking Here.
Investing In Indian Stocks With a Bit of Sense and Lots Of News. Timing Market To Make Big Bucks.
Download today's file by :Clicking Here.
Posted by Analyst at 9:35 AM
Labels: Intraday Calls.
Download today's file by Clicking Here.
Posted by Analyst at 10:14 AM
Labels: Intraday Calls.
I was just reading an article on wordpad. Here's a preview of it:
New cancer treatment hailed as a breakthrough, but since it's based on a common, non-patented drug, it may be hard to find money for clinical trails:
A simple molecule, used for decades to treat children with rare metabolic diseases, commits "immortal" cancer cells to a natural death and could soon be used to treat many forms of cancer, according to a new study.
University of Alberta researchers were excited to discover that dichloroacetate (DCA) causes regression in several cancers, including lung, breast and brain tumours.
....
DCA, a non-toxic compound comprised of "a couple of oxygens, a couple of chlorides and a couple of carbons," appears to repair the damage that cancer cells cause to mitochondria -- the energy- producing units in cells.
Mitochondria regulate cell death and because cancer cells suppress their mitochondria, they achieve "immortality," Dr. Michelakis said. This appears to offer cancer cells a significant advantage in growth compared to normal cells as well as protection from many standard chemotherapies, he said.
DCA "puts life into the mitochondria," making cancer cells more susceptible to apoptosis -- a natural cell suicide mechanism that enables a person to control cell numbers and kill off cells that threaten his or her survival, he said.
DCA, being so small, is easily absorbed into the body, and after oral intake, it can reach areas in the body that other drugs cannot -- making it possible to treat brain cancers.
It could one day be used in conjunction with traditional chemotherapies, Dr. Michelakis said.
"The DCA will enable the cell death mechanisms and then chemotherapy would have a much easier job; you could use lower doses and [the chemotherapy would be] less toxic," he said.
DCA affects cancer cells without affecting normal ones, he added.
Because the inexpensive drug has been used on both healthy and ill patients for 30 years, it can be immediately tested on people suffering from cancer, Dr. Michelakis said.
But because DCA is not patented and is not owned by a pharmaceutical company, it will be a challenge to find funding to begin clinical trials, he said.
There are many such cases in madicines that needs fundings and does have many problems....Was trying to find solution to such things and here's is one bright idea. Do Read On:
There are thousands of promising drugs for treating diseases that are simply not getting studied or brought to market because they are derived from natural or common substances that can't be patented. The dirty little secret of the pharma business is that even a miracle cure for cancer won't be invested in if it can't be defended as a proprietary product.
So here's an idea for the ultra-rich (if you are reading this). If you really want to help the world, start a foundation that funds "open-source medicine" -- the research, development, trials and distribution of non-patentable (or at least non-patented...) drugs. This includes not only herbal and traditional remedies, but also other remedies derived from common substances that just cannot be patented. And in addition it includes potentially patentable cures, which are found and then deliberately released as open-source so that nobody can patent them.
Open-source development has made a huge difference for software, so why not pharma and medicine? Why should all drug development be commercial?
Your shiny new foundation would bring together the greatest minds to collaboratively cure diseases for the betterment of mankind. Now that would be a great legacy!
I am not at all saying such institue should sell drugs at free!! But this would bring a pool of genius together specially in country like India we do need such things. Dont we?
Posted by Analyst at 10:42 PM
Labels: Not Stocks.
Russian Intelligence Report : Click Here.
Posted by Analyst at 2:50 PM
Labels: Intraday Calls.
Download Today's File By Clicking Here.
Posted by Analyst at 9:43 AM
Labels: Intraday Calls